The CPhI North America Conference agenda includes discussions on pharmaceutical manufacturing, outsourcing, R&D, drug delivery and supply chain related topics for small and large molecule finished drugs, biopharmaceuticals, and biosimilars/biogenerics. With three designated tracks of programming: two tracks dedicated to pharmaceutical manufacturing, outsourcing, R&D, drug delivery and supply chain related topics for small and large molecule finished drugs, and one track dedicated to advancements in bio-manufacturing, the central theme for 2018’s conference is “Fostering Innovation in Drug Development and Manufacturing.” Specifically, the conference program will explore the latest developments in the following areas:

• Novel Drug Delivery Systems – Emerging Technologies;
• R&D Innovation;
• Regulatory Developments;
• Continuous Manufacturing Advancements;
• Process Development;
• Tech Transfer;
• Quality Metrics / Supply Chain Best Practices; and
• Bio-Manufacturing Opportunities and Challenges.

There is a full schedule featuring more than 30 sessions presented by leading industry figures and influencers. In addition to the conference program, a series of Insight Briefings, in-depth seminars on technical and business topics, will be accessible to all exhibition visitors. Topics include accelerated drug approval programs, the digital transformation of the pharmaceutical industry, supply chain security advancements, amongst others. There will also be a number of free Exhibitor Showcases taking place, providing a platform for industry professionals to present forward-thinking perspectives on their key products, innovations and services. Finally, the pharmaceutical Serialization Series provide a forum for thought leaders to present and discuss the latest insights and developments within the Serialization sector.

CPhI North America will take place April 24-26, 2018 at the Pennsylvania Convention Center in Philadelphia. It will feature an expanded show footprint ideal for networking, sourcing, education and innovation in drug development and manufacturing. Two new zones including a Bioprocessing Zone and the P-MEC Zone, a machinery zone to promote the latest technology in manufacturing equipment, will join legacy zones, InformEx, iCSE, FDF, InnoPack and CPhI.